Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in ...

Most clinical trials test new treatments only after cancer has relapsed and grown large enough to be detected on scans. The ...

DelveInsight’s Marginal Zone Lymphoma pipeline report depicts a robust space with 50+ active players working to develop 50+ ...

DZD8586 demonstrated significant anti-tumor efficacy in heavily pretreated chronic lymphocytic leukemia/small lymphocytic ...

Elevated LDH and higher international prognostic index were also predictors of poor outcomes on bispecific antibodies, ...

diffuse large B-cell lymphoma, n = 1; follicular lymphoma, n = 1; administrational reason, n = 1). Five-year FFS probability estimates were 31% (95% CI, 26% to 37%) for R-CHOP and 31% (95% CI, 25% to ...

Historically, the presence of measurable disease has been considered essential to stimulate CAR T-cell expansion and persistence. However, the kinetics of CAR T cells in patients achieving complete ...

Clear signs of immune activation: ICT01 at the 10 mg dose provided optimal activation of γ9δ2 T cells and a downstream immune ...

Recursion Pharmaceuticals RXRX and Schrodinger SDGR are pioneering the use of artificial intelligence (AI) in drug discovery ...